Estimating Benefits of Therapy in Crohn's Disease in Terms of Indirect Costs
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Neutralization of Inflammation by Inhibiting and Secretory Phospholipase A by Ethanol Extract of L.
Giresha A, Pramod S, Sathisha A, Dharmappa K Pharmacognosy Res. 2017; 9(2):174-181.
PMID: 28539742 PMC: 5424559. DOI: 10.4103/0974-8490.204650.
References
1.
Bernstein C, Papineau N, Zajaczkowski J, Rawsthorne P, Okrusko G, Blanchard J
. Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital. Am J Gastroenterol. 2000; 95(3):677-83.
DOI: 10.1111/j.1572-0241.2000.01845.x.
View
2.
Odes S
. How expensive is inflammatory bowel disease? A critical analysis. World J Gastroenterol. 2008; 14(43):6641-7.
PMC: 2773305.
DOI: 10.3748/wjg.14.6641.
View
3.
Panaccione R, Loftus Jr E, Binion D, McHugh K, Alam S, Chen N
. Efficacy and safety of adalimumab in Canadian patients with moderate to severe Crohn's disease: results of the Adalimumab in Canadian SubjeCts with ModErate to Severe Crohn's DiseaSe (ACCESS) trial. Can J Gastroenterol. 2011; 25(8):419-25.
PMC: 3186726.
DOI: 10.1155/2011/724813.
View